CIK 0001613780 · Non-accelerated filer<br>Smaller reporting company
DBV Technologies S.A.
Sign in to watch- Ticker
- DBVTF
- Exchange
- Nasdaq, OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- France
- Entity type
- operating
- Phone
- 330155427878
- Business address
- 107 AVENUE DE LA REPUBLIQUE, CHATILLON, France
Securities
- DBVT American Depositary Shares Nasdaq
- DBVTF Common stock OTC
- 8-K Event Executive or director change · Regulation FD disclosure
- 8-K Event Other events
- 424B5 Offering Prospectus
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Open-market sale Chief Medical Officer sold 464 shares at $2.22 ($1,030)
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 8-K Event Other events
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Executive or director change · Bylaws or fiscal year change · Shareholder vote results
- EFFECT Other Notice of Effectiveness
- 424B3 Offering Prospectus
- 4 Open-market sale Chief Medical Officer sold 397 shares at $1.84 ($730)
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- 3 Insider Initial Statement of Ownership
- S-3 Offering Registration Statement
- ARS Other Annual Report to Security Holders
- DEF 14A Proxy Proxy Statement
Page 4 of 29 · 577 filings